Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

iSoft Group PLC (IOT)

  Print      Mail a friend

Tuesday 10 February, 2004

iSoft Group PLC


iSoft Group PLC
10 February 2004

10 February 2004

                           iSOFT Group plc ("iSOFT")

         Disposal of the Torex Retail Business for up to £66.9 million

iSOFT, a leading international supplier of healthcare information systems which
support patient, clinical and business management processes in hospitals and
healthcare provider organisations, announces the sale on 9 February 2004 of the
Torex Retail Business for up to £66.9 million to Lynxangel (Holdings) PLC 
("Lynxangel"), a company established for the purpose of this acquisition. The
Torex Retail Business comprises Torex Retail Limited, Torex Retail (Holdings)
Limited and their respective subsidiary undertakings, together with 69.8 per
cent of the issued share capital of Logware Informationssysteme GmbH.

The sum of £66.9 million comprises (i) £45.0 million paid in cash on completion
which is inclusive of the repayment of intra-group debt, (ii) £14.2 million of
loan notes, and (iii) £5.3 million of ongoing liabilities which relate to the
Torex Retail Business but which would otherwise have been payable by the iSOFT
Group.  The loan notes are to be redeemed on 9 February 2005 or, if earlier, the
date of any IPO or sale of Lynxangel or a material part of its business.  If the
loan notes are redeemed on 9 February 2005, they will be redeemed at their face
value of £14.2 million.  If, however, they are redeemed on an IPO or sale of
Lynxangel or a sale of a material part of its business, they will be redeemed at
a 17 per cent premium to their face value.

The Torex Retail Business, which is involved in supplying IT solutions to the UK
and Irish retail sectors, made pre tax profits of £7.1 million on turnover of
£59.7 million in the year ended 31 December 2003.  At that date, its net assets
were £14.1 million.

As a result of the disposal, iSOFT's continuing activities will be wholly
focused on the provision of technologically advanced software applications to
healthcare provider organisations in the UK and internationally.  The proceeds
from the disposal will be used in part to reduce group indebtedness and as to
the balance for general working capital purposes.

Commenting on the disposal, Tim Whiston, Chief Executive of iSOFT, said:

"The disposal will ensure that iSOFT's focus is maintained exclusively on the
healthcare information systems market.  We are very well placed in both the UK
and overseas and the swift conclusion of this disposal and focus on our core
business will enable us to drive all our efforts towards converting the many
opportunities open to us in the healthcare marketplace."


iSOFT Group plc: +44 (0) 161 935 8800
Mark Woodbridge, Business Development Director
John Whelan, European Finance Director

Hoare Govett Limited: +44 (0) 20 7678 8000
Chris Fielding
Andrew Chapman

Financial Dynamics: +44 (0) 20 7831 3113
Giles Sanderson
James Melville-Ross

                      This information is provided by RNS
            The company news service from the London Stock Exchange

a d v e r t i s e m e n t